Shanghai Allist Pharmaceuticals Co. Ltd. Class ASSE: 688578

"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

Sep 8, 2026 · Issued by Shanghai Allist Pharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Shanghai Allist Pharmaceuticals Co. Ltd. Class A

"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026Aug 27
"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026Aug 20
"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026Jul 17
"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Abnormal Fluctuations in Stock TradingJul 4

All Shanghai Allist Pharmaceuticals Co. Ltd. Class A news releases